Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data
Oncology Research · 2026 · 34 (7) · 1-10
DOI: 10.32604/or.2026.077700 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Oncology Research, 2026. Verfasst von Lorenzo Gasperoni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Department, USL Toscana Centro, Prato, Italy. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Department, USL Toscana Centro, Prato, Italy.
- Department of Pharmacy, School of Specialization in Hospital Pharmacy, University of Pisa, Pisa, Italy.
- Medical Oncology, Breast & GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
- HTA Unit, Regional Health Service, Firenze, Italy.
- Italian Society of Clinical Pharmacy and Therapeutics (SIFaCT), Torino, Italy.
- Hospital Pharmacy Department, Azienda Ulss 2 Marca Trevigiana, Treviso, Italy.
ORCID-Profile: Lorenzo Gasperoni
Zitieren
APA
Gasperoni, L., Del Bono, L., Farolfi, A., Messori, A., & Damuzzo, V. (2026). Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data. Oncology Research, 34(7), 1-10. https://doi.org/10.32604/or.2026.077700
Vancouver
Gasperoni L, Del Bono L, Farolfi A, Messori A, Damuzzo V. Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data. Oncology Research. 2026;34(7):1-10. doi:10.32604/or.2026.077700
BibTeX
@article{Gasperoni2026,
author = {Gasperoni, Lorenzo and Del Bono, Luna and Farolfi, Alberto and Messori, Andrea and Damuzzo, Vera},
title = {Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {7},
pages = {1--10},
doi = {10.32604/or.2026.077700}
}
EUVIMED